New Orleans Habitat for Humanity project beckons to SNM meeting volunteers
The molecular imaging community will lend a hand to help rebuild New Orleans during a special event June 13 before the start of the 2008 Society of Nuclear Medicine meeting.
The molecular imaging community will lend a hand to help rebuild New Orleans during a special event June 13 before the start of the 2008 Society of Nuclear Medicine meeting.
IBA Molecular, a radiopharmacy chain in Louvain-la-Neuve, Belgium, has arranged for a day of volunteer construction help through the New Orleans area Habitat for Humanity. The charity is using volunteers to build replacement houses in Musician's Village, the Ninth Ward, and other hurricane-damaged neighborhoods of the city.
About half of 50 volunteer slots were filled the first day after the event was announced March 18, according to Jill Epperson, trade show and marketing coordinator. Construction efforts continue throughout New Orleans and surrounding communities to repair the damage from Hurricanes Katrina and Rita. The storms killed an estimated 1464 people in Louisiana and Mississippi and destroyed tens of thousands of houses and commercial buildings in August and September 2005.
Expert construction skills are not required, though volunteers must be at least 18 years old to participate, Epperson said. They will be transported by bus from the Renaissance Art Hotel to the Habitat for Humanity construction site at 7 a.m. Work will end before 5 p.m.
For information, contact Epperson at 815-328-7150 or jill.epperson@iba-group.com.
IBA Molecular operates 35 radiopharmacies distributing F-18 FDG and other radiopharmaceutical agents for diagnosis and radiotherapy in North America, Europe, and Asia.
For more information from the Diagnostic Imaging archives:
One year later, Katrina leaves hospitals hurting
New Orleans VA medical center restores data lost to Katrina
Hurricane Katrina bursts PACS myths for Louisiana radiologists
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
